Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatric Infect Dis Soc ; 10(3): 289-294, 2021 Apr 03.
Article in English | MEDLINE | ID: mdl-32667036

ABSTRACT

BACKGROUND: Encephalitis is a severe neurological syndrome associated with significant morbidity and mortality. The California Encephalitis Project (CEP) enrolled patients for more than a decade. A subset of patients with acute and fulminant cerebral edema was noted. METHODS: All pediatric encephalitis patients with cerebral edema referred to the CEP between 1998 and 2012 were reviewed. A case definition was developed for acute fulminant cerebral edema (AFCE) that included the CEP case definition for encephalitis and progression to diffuse cerebral edema on neuroimaging and/or autopsy, and no other recognized etiology for cerebral edema (eg, organic, metabolic, toxin). Prodromic features, demographic and laboratory data, neuroimaging, and outcomes were compared with non-AFCE encephalitis cases. RESULTS: Of 1955 pediatric cases referred to the CEP, 30 (1.5%) patients met the AFCE case definition. The median age for AFCE and non-AFCE cases was similar: 8.2 years (1-18 years) and 8.0 years (0.5-18 years), respectively. Asian-Pacific Islanders comprised a larger proportion of AFCE cases (44%) compared with non-AFCE cases (14%, P < .01). AFCE cases often had a prodrome of high fever, vomiting, and profound headache. Mortality among AFCE patients was significantly higher than among non-AFCE patients (80% vs 13%, P < .01). A confirmed etiology was identified in only 2 cases (enterovirus, human herpes virus type 6), while 10 others had evidence of a respiratory pathogen.Thirty pediatric patients referred to the California Encephalitis Project with a unique, and often fatal, form of encephalitis are reported. Demographic and clinical characteristics, possible etiologies and a proposed case definition for acute fulminant cerebral edema (AFCE) are described. CONCLUSIONS: AFCE is a recently recognized phenotype of encephalitis with a high mortality. AFCE may be triggered by common pediatric infections. Here, we propose a case definition.


Subject(s)
Brain Edema , Encephalitis , Enterovirus Infections , Brain Edema/etiology , Child , Encephalitis/diagnosis , Humans , Neuroimaging , Phenotype
2.
Pediatr Infect Dis J ; 28(1): 67-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19034067

ABSTRACT

We describe a case of group B streptococcal endocarditis in a 15-year-old girl after an elective abortion. There are only 6 reports of group B streptococcal endocarditis in older children. It is a well described but rare complication of surgical abortions, and tends to have an aggressive course.


Subject(s)
Abortion, Induced/adverse effects , Endocarditis, Bacterial/microbiology , Streptococcal Infections/microbiology , Streptococcus agalactiae/isolation & purification , Adolescent , Anti-Bacterial Agents/therapeutic use , Endocarditis, Bacterial/drug therapy , Endocarditis, Bacterial/pathology , Female , Humans , Pregnancy , Streptococcal Infections/drug therapy , Streptococcal Infections/pathology
3.
Neurocrit Care ; 9(1): 74-82, 2008.
Article in English | MEDLINE | ID: mdl-18097641

ABSTRACT

BACKGROUND: The California Encephalitis Project (CEP) is a program designed to determine causes of encephalitis. We sought to determine whether there are any distinguishing characteristics of patients with encephalitis who develop refractory status epilepticus from those who do not. METHODS: Data from all patients in the CEP were retrospectively reviewed and analyzed. Diagnostic testing was performed for a panel of infectious agents and medical information collected using a standardized form. Encephalitis patients were subdivided into three categories: (i) patients with status epilepticus unresponsive to standard antiepileptic therapy who required general anesthetic coma for management (Group I), (ii) patients with seizures or status epilepticus responsive to standard antiepileptic therapy (Group II), and (iii) patients without seizures (Group III). Supplementary information was requested on Group I patients. RESULTS: Of 1,151 patients; 43 (4%) were classified as Group I, 459 (40%) as Group II, and 649 (56%) as Group III. Compared to Groups II and III, Group I patients were younger (median age = 10.0 years), more likely to have fever (93%), prodromal respiratory (57%) or gastrointestinal illness (64%), and less likely to have CSF pleocytosis (47%) or abnormal neuroimaging (16%). A causative infectious agent was verified in three of the Group I patients; and a putative agent in nine others. Supplementary information on Group I revealed that 28% died within 2 years and 56% were neurologically impaired or undergoing rehabilitation. CONCLUSIONS: Encephalitis and refractory status epilepticus occur most commonly in the pediatric age group, an infectious etiology is usually not established, and outcomes are generally poor.


Subject(s)
Anticonvulsants/therapeutic use , Encephalitis/epidemiology , Status Epilepticus/drug therapy , Status Epilepticus/epidemiology , Age Distribution , Child , Child, Preschool , Drug Resistance , Encephalitis/complications , Female , Humans , Infant , Male , Medical History Taking , Multivariate Analysis , Prognosis , Status Epilepticus/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...